Nanbin Liu
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Integrative multi-omics and experimental validation reveal the oncogenic role of DDX52 in liver hepatocellular carcinoma.
Journal: Molecular and cellular probes
Published: April 26, 2026
Integrated pan-cancer profiling and experimental validation identify CCDC59 as a key driver and therapeutic biomarker in liver hepatocellular carcinoma.
Journal: Pathology, research and practice
Published: February 04, 2026
Multi-omics integration identifies ribosome biogenesis-active macrophage subpopulation and its key gene GNL2 in driving liver hepatocellular carcinoma progression and mechanisms.
Journal: Cancer cell international
Published: October 27, 2025
Macrophage DHX34 as a negative regulator of the CX3CL1-CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma.
Journal: International immunopharmacology
Published: October 14, 2025
RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation.
Journal: Journal of Cancer
Published: September 17, 2025
DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation.
Journal: Journal of Cancer
Published: August 12, 2024
LACTB suppresses liver cancer progression through regulation of ferroptosis.
Journal: Redox biology
Published: May 06, 2024
Relationship between postoperative biliary stricture and clinical characteristics of patients with benign and malignant biliary diseases.
Journal: Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques
Published: September 30, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026